martes, 1 de octubre de 2013

Novartis: Hard to say i'm sorry / ソーリー a la japonesa (o...a los japoneses).

(Reuters) - The pharmaceutical head at Swiss firm Novartis AG apologised to the Japanese public for alleged manipulation of data in trials of its best-selling blood pressure drug Diovan, saying an employee had acted inappropriately. 

Divisional head David Epstein made the comments after meeting with Japanese health minister Norihisa Tamura in Tokyo. He agreed to cooperate with the ministry to resolve the issue.


"We express our deep regret for the concern that the issue has brought to patients, to the medical society as well as the ministry," Epstein said. (Más)

Ver también:

VALSARTAN: Harakiri a la investigación Novartis...en Japón.

Publicar un comentario